The impact of mild behavioral impairment on the prognosis of geriatric depression : preliminary results
Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc..
Our study aimed to examine how the presence of Mild Behavioral Impairment (MBI) symptoms influenced the outcome of late-life depression (LLD). Twenty-nine elderly (≥ 60 years) depressive patients, including eleven (37.9%) with MBI, were recruited and followed-up on average for 33.41 ± 8.24 weeks. Psychiatric symptoms severity and global functioning were assessed, respectively, using the Brief Psychiatric Rating Scale (BPRS) and the Global Assessment of Functioning (GAF) scale. BPRS total score significantly decreased from baseline to follow-up (P < 0.001, d = 1.33). The presence of MBI had no significant effect on mood and cognitive symptoms improvement. On the contrary, while a significant increase in GAF score was observed in patients without MBI (P = 0.001, d = 1.01), no significant improvement of global functioning was detected in those with MBI (P = 0.154, d = 0.34) after 6-month follow-up. The presence of MBI in patients with LLD may negatively affect long-term outcome, slowing or preventing functional improvement.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - year:2023 |
|---|---|
| Enthalten in: |
International clinical psychopharmacology - (2023) vom: 15. Nov. |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Elefante, Camilla [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Revised 15.11.2023 published: Print-Electronic Citation Status Publisher |
|---|
| doi: |
10.1097/YIC.0000000000000521 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM364577614 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM364577614 | ||
| 003 | DE-627 | ||
| 005 | 20231226095727.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1097/YIC.0000000000000521 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1215.xml |
| 035 | |a (DE-627)NLM364577614 | ||
| 035 | |a (NLM)37966156 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Elefante, Camilla |e verfasserin |4 aut | |
| 245 | 1 | 4 | |a The impact of mild behavioral impairment on the prognosis of geriatric depression |b preliminary results |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 15.11.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status Publisher | ||
| 520 | |a Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. | ||
| 520 | |a Our study aimed to examine how the presence of Mild Behavioral Impairment (MBI) symptoms influenced the outcome of late-life depression (LLD). Twenty-nine elderly (≥ 60 years) depressive patients, including eleven (37.9%) with MBI, were recruited and followed-up on average for 33.41 ± 8.24 weeks. Psychiatric symptoms severity and global functioning were assessed, respectively, using the Brief Psychiatric Rating Scale (BPRS) and the Global Assessment of Functioning (GAF) scale. BPRS total score significantly decreased from baseline to follow-up (P < 0.001, d = 1.33). The presence of MBI had no significant effect on mood and cognitive symptoms improvement. On the contrary, while a significant increase in GAF score was observed in patients without MBI (P = 0.001, d = 1.01), no significant improvement of global functioning was detected in those with MBI (P = 0.154, d = 0.34) after 6-month follow-up. The presence of MBI in patients with LLD may negatively affect long-term outcome, slowing or preventing functional improvement | ||
| 650 | 4 | |a Journal Article | |
| 700 | 1 | |a Brancati, Giulio Emilio |e verfasserin |4 aut | |
| 700 | 1 | |a Pistolesi, Gabriele |e verfasserin |4 aut | |
| 700 | 1 | |a Amadori, Salvatore |e verfasserin |4 aut | |
| 700 | 1 | |a Torrigiani, Samuele |e verfasserin |4 aut | |
| 700 | 1 | |a Baldacci, Filippo |e verfasserin |4 aut | |
| 700 | 1 | |a Ceravolo, Roberto |e verfasserin |4 aut | |
| 700 | 1 | |a Ismail, Zahinoor |e verfasserin |4 aut | |
| 700 | 1 | |a Lattanzi, Lorenzo |e verfasserin |4 aut | |
| 700 | 1 | |a Perugi, Giulio |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t International clinical psychopharmacology |d 1995 |g (2023) vom: 15. Nov. |w (DE-627)NLM013124765 |x 1473-5857 |7 nnns |
| 773 | 1 | 8 | |g year:2023 |g day:15 |g month:11 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1097/YIC.0000000000000521 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |j 2023 |b 15 |c 11 | ||